Showing results (1-10 of 243) with videos related to
Sort By:
Pageof 25
Expert Opinion on Drug Safety|November 17, 2015
The safety of daclatasvir for the treatment of hepatitis CSyed-Mohammed Jafri, Stuart C GordonInfectious Disease Clinics of North America|October 23, 2012
Care of the cirrhotic patientSyed-Mohammed Jafri, Stuart C GordonExpert Opinion on Drug Metabolism & Toxicology|February 6, 2016
Pharmacodynamics and pharmacokinetics of elbasvir and grazoprevir in the treatment of hepatitis CNimisha Sulejmani, Syed-Mohammed Jafri, Stuart C GordonClinics in Liver Disease|November 16, 2016
Management of Acute Hepatotoxicity Including Medical Agents and Liver Support SystemsHumberto C Gonzalez, Syed-Mohammed Jafri, Stuart C GordonCurrent Gastroenterology Reports|January 16, 2013
Role of liver biopsy in the era of direct-acting antiviralsHumberto C Gonzalez, Syed Mohammed Jafri, Stuart C GordonHepatic Medicine : Evidence and Research|May 17, 2018
Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapyNimisha Sulejmani, Syed-Mohammed JafriJournal of Racial and Ethnic Health Disparities|November 24, 2020
African Americans Demonstrate Significantly Lower Serum Alanine Aminotransferase Compared to Non-African AmericansAdarsh Varma, Sheri Trudeau, Yueren Zhou, et al.ACG Case Reports Journal|August 21, 2023
Transcatheter Aortic Valve Replacement Restoring Candidacy for Liver Transplant in Patients With CirrhosisMirna Kaafarani, Omar Shamma, Syed-Mohammed JafriCurrent Opinion in Gastroenterology|April 4, 2009
What is left of the endoscopic antireflux devices?Syed-Mohammed Jafri, Gaurav Arora, George TriadafilopoulosWorld Journal of Hepatology|October 11, 2021
Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2Emily E Currier, Mohamad Dabaja, Syed-Mohammed JafriPageof 25